Public Comments: ACI Urges FDA to Adopt Science-Based Approach to Flavored Vaping Products ByThe American Consumer Institute May 6, 2026May 13, 2026
The Economic Standard: Stop Forcing Digital Medicine Into Analog Laws ByJustin Leventhal April 24, 2026April 24, 2026
Public Comments: ACI Warns Most Favored Nation Drug Pricing Could Limit Access and Stifle Innovation ByThe American Consumer Institute April 22, 2026April 22, 2026
RealClear Health: The War on Medical AI Is Raising Your Healthcare Bill ByJustin Leventhal April 17, 2026April 17, 2026
The Economic Standard: The FDA’s Backwards War on Vapes ByJustin Leventhal April 17, 2026April 17, 2026
Public Comments: ACI Calls for Structural Reform of 340B Program, Warns Pilot Extension Falls Short ByThe American Consumer Institute April 17, 2026April 22, 2026
Public Comments: Support for the Department of Labor’s Proposed ERISA Rule on PBM Transparency and Pricing Disclosure ByThe American Consumer Institute April 16, 2026April 16, 2026
RealClear Markets: Starting With Prices, Let’s Make Healthcare a Market Again ByJustin Leventhal April 14, 2026April 14, 2026
Coalition Letter: ACI Supports Legislation to Lower Drug Costs ByThe American Consumer Institute April 7, 2026April 8, 2026
DC Journal: How Hospitals Turn Drug Discounts Into Windfalls ByJustin Leventhal April 6, 2026April 8, 2026
